[Form 4] FMC Corporation Insider Trading Activity
Jacqueline Scanlan, Executive VP & Chief HRO of FMC Corporation (FMC), reported a sale of 1,510 shares of FMC common stock on 08/18/2025 at a price of $37.49 per share, reducing her beneficial ownership to 36,834 shares.
Rhea-AI Filing Summary
Jacqueline Scanlan, Executive VP & Chief HRO of FMC Corporation (FMC), reported a sale of 1,510 shares of FMC common stock on 08/18/2025 at a price of $37.49 per share, reducing her beneficial ownership to 36,834 shares. The filing indicates the transaction was made pursuant to a Rule 10b5-1 plan. The Form 4 was signed by an attorney-in-fact on 08/19/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR Insider sale of 1,510 shares via a 10b5-1 plan; small relative holding change, likely routine liquidity.
The sale of 1,510 shares at $37.49 is disclosed transparently and flagged as executed under a Rule 10b5-1 plan, which typically indicates a prearranged, non-discretionary trade. The remaining beneficial position of 36,834 shares provides context on her total exposure to FMC equity. There are no derivative transactions or other material changes reported. For investors, this represents routine insider selling rather than a material corporate development.
TL;DR Filing shows compliance with Section 16 disclosure rules and use of a 10b5-1 plan; no governance concerns apparent from this Form 4.
The Form 4 is properly completed: it identifies the reporting person, relationship to the issuer, transaction type, price, and post-transaction ownership. The checked 10b5-1 box and attorney-in-fact signature indicate adherence to procedural controls for insider transactions. There is no indication of undisclosed related-party transactions or amendments. This appears to be a routine, compliant insider sale.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,510 | $37.49 | $57K |
AI-generated analysis. How Rhea-AI works. Not financial advice.